Arctiin treatment for 72 hours yielded a cell viability IC50 of 3.2±0.3 µM in MDA-MB-231 cells. In MCF-7 cells, the cell viability IC50 was >10 µM after 72 hours. In RAW264.7 cells, Arctiin did not affect normal cell growth at concentrations up to 100 μg/ml. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Arctiin and viability in breast cancer cells
Cell-based study · MDA-MB-231 cells [1]
MDA-MB-231 cells were treated with Arctiin for 72 hours, with vehicle controls. The cell viability IC50 was 3.2±0.3 µM.
Literature-Reported Treatment Conditions
- Treatment concentration
- 20 µM to 1.2 nM
- Exposure duration
- 72 hours
- Method
- culture media containing either vehicles or drug were added
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Arctiin
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Cell Proliferation Assays (S55, S56, S58); Results > Hit Compounds Inhibit the Growth of AdipoR1/AdipoR2– Positive Cancer Cell Lines (S116); Table 3 (T3.h1, T3.h2, T3.r1)
cell viability: cell viability; comparator: vehicle controls — Results > Hit Compounds Inhibit the Growth of AdipoR1/AdipoR2– Positive Cancer Cell Lines (S116); Table 3 (T3.h1, T3.h2, T3.r1)
Arctiin and normal cell growth
Cell-based study · RAW264.7 cells [2]
RAW264.7 cells were treated with Arctiin at concentrations up to 100 μg/ml. Arctiin did not affect normal cell growth at these concentrations.
Literature-Reported Treatment Conditions
- Treatment concentration
- up to 100 μg/ml
- Method
- plated with various concentrations of arctiin
- Reported limits
- Not stated in the sentences used: schedule, vehicle, control.
Methods and source locations
Compound reported in the paper: Arctiin
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Methods > Cell viability assay (S18, S19); Results (S51); Figure 1 legend (S77)
Cell viability: Cell viability — Results (S51); Figure 1 legend (S77)
Arctiin and viability in mammary cells
Cell-based study · MCF-7 cells [1]
MCF-7 cells were treated with Arctiin for 72 hours, with vehicle controls. The cell viability IC50 was >10 µM.
Literature-Reported Treatment Conditions
- Treatment concentration
- 20 µM to 1.2 nM
- Exposure duration
- 72 hours
- Method
- culture media containing either vehicles or drug were added
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Arctiin
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Cell Proliferation Assays (S55, S56, S58); Results > Hit Compounds Inhibit the Growth of AdipoR1/AdipoR2– Positive Cancer Cell Lines (S116); Table 3 (T3.h1, T3.h2, T3.r1)
cell viability: cell viability; comparator: vehicle controls — Results > Hit Compounds Inhibit the Growth of AdipoR1/AdipoR2– Positive Cancer Cell Lines (S116); Table 3 (T3.h1, T3.h2, T3.r1)